Post by Lonza

Is the industry shifting toward an integrated CDMO offering or modality-specific expertise? In Pharma's Almanac June Roundtable, Christian Seufert, Head of Advanced Synthesis, outlines how the industry is moving toward partnership models that require both. Integrated outsourcing models provide a seamless ecosystem that reduces risk and accelerates timelines, while modality-specific expertise is becoming increasingly critical as complexity grows, particularly for bioconjugates such as ADCs. At Lonza, we connect drug substance and drug product manufacturing through advanced platforms and a global network, supporting consistent quality from early development through commercialization. Reach Christian’s insights in the latest roundtable here: https://ow.ly/4J4650Zj2Rm #Lonza #CDMO #ADCs #Bioconjugates #PharmaceuticalsManufacturing #Innovation